Abbott Sells Developed Markets Branded Generics Business to Mylan in Spinversion
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 9 (Table of Contents)
Published: 3 Sep-2014
DOI: 10.3833/pdr.v2014.i9.2058 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Abbott has agreed to sell its ex-US developed markets branded generics pharmaceuticals business to Mylan in exchange for a 21% equity stake in a new public company based in the Netherlands that will also include Mylan’s existing business...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS